Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC

C. Pinto, N. Normanno, A. Orlandi, F. Fenizia, A. Damato, E. Maiello, E. Tamburini, F. Di Costanzo, G. Tonini, D. Bilancia, D. Corsi, S. Pisconti, F. Ferrau, S. Gori, B. Daniele, A. Zaniboni, H. Soto Parra, Giovanni Luca Paolo Frassineti, R.V. Iaffaioli, A. CassataM.G. Zampino, L. Repetto, M.A. Calegari, C. Barone

Research output: Contribution to journalArticle

Original languageItalian
Pages (from-to)1339-1346
Number of pages8
JournalFuture Oncology
Volume14
Issue number14
DOIs
Publication statusPublished - 2018

Cite this